High‐Efficiency Ocular Delivery of Brain‐Derived Neurotrophic Factor and Oligomycin for Neuroprotection in Glaucoma
Advanced Materials · 2025
DOI: 10.1002/adma.202500623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Yuheng Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Nano-Bio Interface, Suzhou Key Laboratory of Functional Molecular Imaging Technology, Division of Nanobiomedicine and i-Lab, Su…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Glaucoma, Neuroprotective Agents, Neuroprotection. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Glaucoma is a retinal neurodegenerative disease characterized by progressive apoptosis of retinal ganglion cells (RGCs) and irreversible visual impairment. Current therapies rarely offer direct protection for RGCs, highlighting the need for new neuroprotective approaches. Although viral delivery of brain‐derived neurotrophic factor (BDNF) has shown potential, concerns about retinal inflammation and limited applicability persist. Meanwhile, non‐viral vectors remain inefficient for in vivo ocular gene delivery. Here, a highly biocompatible nanoplatform—PBAE‐PLGA‐Oligomycin‐pBDNF nanoparticles (PPOB NPs) is reported—that co‐delivers oligomycin (an ATP inhibitor) and a BDNF plasmid to Müller cells in vivo. This nanoplatform attains an unprecedented transfection efficiency of 64.26% in Müller cells, thereby overcoming the limitations of monotherapeutic neurotrophic approaches that fail to inhibit ATP overproduction and attendant inflammatory responses. In a chronic ocular hypertension rat model, oligomycin effectively mitigated RGC damage by suppressing Müller cell hyperactivation and excessive ATP production under elevated intraocular pressure. Concurrently, it synergistically enhanced BDNF expression in Müller cells, achieving robust protection of RGCs and preservation of optic nerve function. These findings underscore the promise of PPOB NPs as a dual‐functional platform, featuring high biocompatibility and efficient gene delivery, for multifaceted therapies against glaucoma and other ocular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Nano-Bio Interface, Suzhou Key Laboratory of Functional Molecular Imaging Technology, Division of Nanobiomedicine and i-Lab, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Scien…
- School of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
- Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, 21006, China.
- School of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei, 230026, China.
ORCID-Profile: Yuheng Cao, Guangcun Chen, Qiangbin Wang
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Natural Science Foundation of Jiangsu Province
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Science and Technology Project of Suzhou
- Suchow Pilot Initiative for Fundamental Research
- National Key Research and Development Program of China
Zitieren
APA
Cao, Y., Yin, X., Wu, L., Huang, D., Wang, Z., Wu, F., Jiang, J., Chen, G., & Wang, Q. (2025). High‐Efficiency Ocular Delivery of Brain‐Derived Neurotrophic Factor and Oligomycin for Neuroprotection in Glaucoma. Advanced Materials. https://doi.org/10.1002/adma.202500623
Vancouver
Cao Y, Yin X, Wu L, Huang D, Wang Z, Wu F, et al. High‐Efficiency Ocular Delivery of Brain‐Derived Neurotrophic Factor and Oligomycin for Neuroprotection in Glaucoma. Advanced Materials. 2025. doi:10.1002/adma.202500623
BibTeX
@article{Cao2025,
author = {Cao, Yuheng and Yin, Xue and Wu, Lanrong and Huang, Dehua and Wang, Zheng and Wu, Feng and Jiang, Jiang and Chen, Guangcun and Wang, Qiangbin},
title = {High‐Efficiency Ocular Delivery of Brain‐Derived Neurotrophic Factor and Oligomycin for Neuroprotection in Glaucoma},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202500623}
}
EUVIMED